MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
407.18%
Quick Ratio
407.18%
Cash Ratio
69.21%
Debt to Asset Ratio
29.38%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Right-of-use asset
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Total current liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
26,329
21,756
35,256
47,532
Marketable securities
125,428
59,798
67,958
7,425
Prepaid expenses and other current assets
3,141
3,039
2,478
3,373
Total current assets
154,898
84,593
105,692
58,330
Restricted cash
3,405
3,235
3,235
3,235
Property, plant and equipment, gross
-
-
12,042
-
Less accumulated depreciation
-
-
6,929
-
Property and equipment, net
4,397
4,722
5,113
5,531
Right-of-use asset
26,389
26,778
27,165
27,549
Other assets
-
-
-
110
Prepaid expenses and other non-current assets
274
314
110
-
Total assets
189,363
119,642
141,315
94,755
Accounts payable
2,032
2,069
3,983
2,533
Accrued expenses and other current liabilities
7,983
5,938
12,533
12,930
Deferred revenue
25,248
30,952
33,734
-
Operating lease liability
2,779
2,761
2,744
2,727
Finance lease liability
-
-
0
0
Total current liabilities
38,042
41,720
52,994
18,190
Deferred revenue, net of current portion
0
0
1,798
-
Other liabilities
2,717
2,779
2,841
2,904
Operating lease liability
14,871
14,960
15,045
15,127
Total liabilities
55,630
59,459
72,678
36,221
Common stock-Voting Common Stock
7
5
5
4
Common stock-Nonvoting Common Stock
1
1
1
1
Additional paid-in capital
841,319
753,664
751,684
725,131
Accumulated other comprehensive (loss) income
-227
-41
8
2
Accumulated deficit
-707,367
-693,446
-683,061
-666,604
Total stockholders equity
133,733
60,183
68,637
58,534
Total liabilities and stockholders equity
189,363
119,642
141,315
94,755
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$125,428K
(164.26%↑ Y/Y)
Cash and cash
equivalents
$26,329K
(2.24%↑ Y/Y)
Prepaid expenses and
other current assets
$3,141K
(-14.18%↓ Y/Y)
Total current assets
$154,898K
(101.49%↑ Y/Y)
Right-of-use asset
$26,389K
(-5.52%↓ Y/Y)
Property and equipment,
net
$4,397K
(-26.18%↓ Y/Y)
Restricted cash
$3,405K
(-15.80%↓ Y/Y)
Prepaid expenses and
other non-current...
$274K
Total assets
$189,363K
(64.78%↑ Y/Y)
Total liabilities and
stockholders equity
$189,363K
(64.78%↑ Y/Y)
Total stockholders
equity
$133,733K
(76.34%↑ Y/Y)
Total liabilities
$55,630K
(42.35%↑ Y/Y)
Accumulated deficit
-$707,367K
(-9.35%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$227K
(-22600.00%↓ Y/Y)
Additional paid-in capital
$841,319K
(16.41%↑ Y/Y)
Total current
liabilities
$38,042K
(81.95%↑ Y/Y)
Operating lease liability
$14,871K
(-2.20%↓ Y/Y)
Other liabilities
$2,717K
(-8.40%↓ Y/Y)
Common stock-Voting
Common Stock
$7K
(75.00%↑ Y/Y)
Common
stock-Nonvoting Common Stock
$1K
(0.00%↑ Y/Y)
Deferred revenue
$25,248K
Accrued expenses and
other current...
$7,983K
(-39.68%↓ Y/Y)
Operating lease liability
$2,779K
(2.51%↑ Y/Y)
Accounts payable
$2,032K
(-59.05%↓ Y/Y)
Buy us a coffee
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)